久久国产成人av_抖音国产毛片_a片网站免费观看_A片无码播放手机在线观看,色五月在线观看,亚洲精品m在线观看,女人自慰的免费网址,悠悠在线观看精品视频,一级日本片免费的,亚洲精品久,国产精品成人久久久久久久

分享

GMP英語(yǔ)詞匯

 百里香華 2010-02-22

GMP英語(yǔ)詞匯

2009-09-11 16:13

 

GMP英語(yǔ)

PIC/S的全稱為:Pharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(制藥檢查草案), 藥品檢查協(xié)會(huì)(PIC/S) ,也有人稱PIC/S為醫(yī)藥審查會(huì)議/合作計(jì)劃(PIC/S)

PIC的權(quán)威翻譯:藥品生產(chǎn)檢查相互承認(rèn)公約

API(Active Pharmaceutical Ingrediet) 原料藥 又稱:活性藥物組分

AirLock 氣閘 Authorized Person 授權(quán)人 Batch/Lot 批次

Batch Number/Lot-Number 批號(hào),;Batch Numbering System 批次編碼系統(tǒng),;

Batch Records 批記錄;Bulk Product 待包裝品,;Calibration 校正,;Clean area潔凈區(qū);Consignmecnt(Delivery)托銷藥品,。

FDA(FOOD AND DRUG ADMINISTRATION):(美國(guó))食品藥品管理局

IND(INVESTIGATIONAL NEW DRUG):臨床研究申請(qǐng)(指申報(bào)階段,相對(duì)于NDA而

言),;研究中的新藥(指新藥開(kāi)發(fā)階段,相對(duì)于新藥而言,,即臨床前研究結(jié)束)

NDA(NEW DRUG APPLICATION):新藥申請(qǐng)

ANDA(ABBREVIATED NEW DRUG APPLICATION):簡(jiǎn)化新藥申請(qǐng)

TREATMENT IND:研究中的新藥用于治療

ABBREVIATED(NEW)DRUG:簡(jiǎn)化申請(qǐng)的新藥

DMF(DRUG MASTER FILE):藥物主文件(持有者為謹(jǐn)慎起見(jiàn)而準(zhǔn)備的保密資料,,可以

包括一個(gè)或多個(gè)人用藥物在制備、加工,、包裝和貯存過(guò)程中所涉及的設(shè)備,、生產(chǎn)過(guò)程或物

品。只有在DMF持有者或授權(quán)代表以授權(quán)書的形式授權(quán)給FDA,,F(xiàn)DA在審查IND,、

NDA、ANDA時(shí)才能參考其內(nèi)容)

HOLDER:DMF持有者

CFR(CODE OF FEDERAL REGULATION):(美國(guó))聯(lián)邦法規(guī)

PANEL:專家小組

BATCH PRODUCTION:批量生產(chǎn),;分批生產(chǎn)

BATCH PRODUCTION RECORDS:生產(chǎn)批號(hào)記錄

POST-OR PRE- MARKET SURVEILLANCE:銷售前或銷售后監(jiān)督

INFORMED CONSENT:知情同意(患者對(duì)治療或受試者對(duì)醫(yī)療試驗(yàn)了解后表示同意接受治療或試驗(yàn))

PRESCRIPTION DRUG:處方藥

OTC DRUG(OVER—THE—COUNTER DRUG):非處方藥

GMP文件常見(jiàn)縮寫

ABPI Association of the British Pharmaceutical Industry

ADR Adverse Drug Reaction

AE Adverse Event

AIM Active Ingredient Manufacturer

ANDA Abbreviated New Drug Application

ANOVA Analysis of Variance

ASM: Active Substance Manufacturer

ATC Anatomical Therapeutic Chemical

ATX Animal Test Exemption Certificate

BAN British Approved Name

BIRA British Institute of Regulatory Affairs

BNF British National Formulary

BP British Pharmacopoeia

C of A Certificate of Analysis

C of S Certificate of Suitability

CENTRE FOR DRUG EVALUATION (CDE)

Centre for Pharmaceutical Administration (CPA)

CMS Concerned Member State

CMS每個(gè)成員國(guó)

COS Certificate of Suitability

CPMP Committee for Proprietary Medicinal Products

CRA Clinical Research Associate

CRF Case Report Form

CRO Contract Research Organisation

CTA Clinical Trial Application

CTC Clinical Trial Certificate

CTD Common Technical Document

CTX Clinical Trials Exemption

DDD Defined Daily Dose

DGC Daily Global Comparison

DIA Drug Information Association

DMF Drug Master File

Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA

EDQM (European Directorate for the Quality of Medicines) 歐洲聯(lián)盟藥品質(zhì)量指導(dǎo)委員會(huì)

EEA 歐洲經(jīng)濟(jì)地區(qū)

EGMA European Generics Medicine Association

ELA Established Licence Application

EMEA European Medicines Evaluation Agency

EMEA (European Agency for the Evaluation of Medicinal Products) 歐洲聯(lián)盟藥品評(píng)價(jià)機(jī)構(gòu)

EP European Pharmacopoeia

EPAR European Public Assessment Reports

ESRA European Society of Regulatory Affairs

European Pharmacopoeia Commission 歐洲藥典委員會(huì)

FDA

FDA Food and Drug Administration

final evaluation report (FER)

free sale certificates (FSCs)

GCP Good Clinical Practice

GCP藥品臨床研究管理規(guī)范

GLP Good Laboratory Practice

GLP 藥品臨床前安全性研究質(zhì)量管理規(guī)范

GMP Good Manufacturing Practice

GMP 藥品生產(chǎn)質(zhì)量管理規(guī)范

GSP藥品銷售管理規(guī)范

Health Sciences Authority (HSA)

HSA’s Medicines Advisory Committee (MAC)

IB Investigators Brochure

ICH International Conference for Harmonisation

IDMC Independent Data-Monitoring Committee

IEC Independent Ethics Committee

IND Investigational New Drug

INN International Non-proprietary Name

International Conference on Harmonisation (ICH)

IPC In Process Control

IRB Institutional Review Board

LICENCE HOLDER

MA Marketing Authorisation

MAA Marketing Authorisation Application

MAA上市申請(qǐng)

MAH Marketing Authorisation Holder

MAH 銷售許可持有者

MCA Medicines Control Agency

MHW Ministry of Health and Welfare (Japan)

MR Mutual Recognition

MRA 美國(guó)與歐盟的互認(rèn)協(xié)議

MRAs (Mutual Recognition Agreements) 互相認(rèn)證同意

MRFG Mutual Recognition Facilitation Group

MRP Mutual Recognition Procedure

NAS New Active Substance

NCE New Chemical Entity

NDA New Drug Application

new chemical entities (NCEs)

new drug applications (NDAs)

NSAID Non Steroidal Anti Inflammatory Drug

NTA Notice To Applicants

OOS Out of Specification

OTC Over The Counter

PAGB Proprietary Association of Great Britain

Ph Eur European Pharmacopoeia

PIL Patient Information Leaflet

PL Product Licence

POM Prescription Only Medicine

PRODUCT OWNER

PSU Periodic Safety Updates

QA Quality Assurance

QC Quality Control

RAJ Regulatory Affairs Journal

RMS Reference Member State

RMS相互認(rèn)可另一成員國(guó)

RSD Relative Standard Deviation

Rx Prescription Only

SAE Serious Adverse Event

SMF Site Master File

SOP Standard Operating Procedure

SOP (STANDARD OPERATION PROCEDURE) 標(biāo)準(zhǔn)運(yùn)作程序

SPC/SmPC Summary of Product Characteristics

summary of product characteristics(SPC)

Therapeutic Goods Administration (TGA)

USP US Pharmacopoeia

VMF Veterinary Master File

VPC Veterinary Products Committee

A.A.A Addition and Amendments 增補(bǔ)和修訂

AC Air Conditioner 空調(diào)器

ADR Adverse Drug Reaction 藥物不良反應(yīng)

AFDO Association of Food and Drug Officials 食品與藥品官員協(xié)會(huì)(美國(guó))

ACC Accept 接受

AQL Acceptable Quality Level 合格質(zhì)量標(biāo)準(zhǔn)

ADNA Abbreviated New Drug Application 簡(jiǎn)化的新藥申請(qǐng)

BOM Bill of Material 物料清單

BPC Bulk pharmaceutical Chemiclls 原料藥

CBER Center for Biologics Evaluation Research 生物制品評(píng)價(jià)與研究中心

CFU Colony Forming Unet 菌落形成單位

DMF Drug Master File 藥品管理檔案

CDER Cemter for Drug Evaluation amd Research 藥物評(píng)價(jià)與研究中心

CI Corporate Identity (Image) 企業(yè)識(shí)別(形象)

CIP Cleaning in Place 在線清洗

CSI Consumer Safety Insepctor 消費(fèi)者安全調(diào)查員

CLP Cleaning Line Procedure 在線清洗程序

DAL Defect Action Level 缺陷作用水平

DEA Drug Enforcement Adminestration 管制藥品管理

DS Documentation Systim 文件系統(tǒng)

FDA Food and Drug Administration 食品與藥品管理局(美國(guó))

GATT General Agreemernt on Tariffs and Trade 關(guān)貿(mào)總協(xié)會(huì)

GMP Good Manufacturing Practice Gvp 藥品生質(zhì)量管理規(guī)范

GCP Good Clinical Practice 藥品臨床實(shí)驗(yàn)管理規(guī)范

GLP Good Laboratory Practice 實(shí)驗(yàn)室管理規(guī)范

GSP Good Supply Practice 藥品商業(yè)質(zhì)量規(guī)范

GRP Gook RaTAIL Practice 藥品零業(yè)質(zhì)量管理規(guī)范

GAP Good Agriculture Practice 藥材生產(chǎn)管理規(guī)范

GVP Gook Validation Prctice 驗(yàn)證管理規(guī)范

GUP Gook Use Practice 藥品重用規(guī)范

HVAC Heating Ventilation Air Conditioning 空調(diào)凈化系統(tǒng)

ISO Intematonal Organization for Standardization 車際標(biāo)準(zhǔn)化組織

MOU Memorandum of Understanding 諒解備忘錄

PF Porduction File 生產(chǎn)記錄用表格

OTC Over the Counter (Drug) 非處方藥品

PLA Product License Application 產(chǎn)品許可申請(qǐng)

QA Quality Assurance 質(zhì)量保證

QC Quality Control 質(zhì)量控制

QMP Quality Management Procedure 質(zhì)量管理程序

SDA State Drug Administration 國(guó)家藥品監(jiān)督管理局

SMP Standard Managmert Procedure 標(biāo)準(zhǔn)管理程序

SOP Standard Operating Procedure 標(biāo)準(zhǔn)操作程序

TQC Tatal Quality Control 全面質(zhì)量管理

USA Uneted States Pharmacopeia 美國(guó)藥典

    本站是提供個(gè)人知識(shí)管理的網(wǎng)絡(luò)存儲(chǔ)空間,,所有內(nèi)容均由用戶發(fā)布,不代表本站觀點(diǎn),。請(qǐng)注意甄別內(nèi)容中的聯(lián)系方式,、誘導(dǎo)購(gòu)買等信息,,謹(jǐn)防詐騙。如發(fā)現(xiàn)有害或侵權(quán)內(nèi)容,,請(qǐng)點(diǎn)擊一鍵舉報(bào),。
    轉(zhuǎn)藏 分享 獻(xiàn)花(0

    0條評(píng)論

    發(fā)表

    請(qǐng)遵守用戶 評(píng)論公約

    類似文章 更多